{"id":51346,"date":"2019-08-11T09:09:35","date_gmt":"2019-08-11T07:09:35","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=51346"},"modified":"2019-10-14T09:04:00","modified_gmt":"2019-10-14T07:04:00","slug":"breath-therapeutics-taken-over","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/51346\/breath-therapeutics-taken-over\/","title":{"rendered":"Exit for biotech startup Breath Therapeutics"},"content":{"rendered":"
\n

The Munich-based startup Breath Therapeutics was acquired by the Italian Zambon Group for a sum of up to 500 million euros<\/strong> bought up. <\/strong><\/p>\n\n\n\n

Breath Therapeutics specializes in the development of inhalation solutions for severe lung diseases. The pharmaceutical company Zambon paid up to 500 million euros for the acquisition. According to Handelsblatt, this could be the third largest takeover in the German biotech sector<\/a>.<\/p>\n\n\n\n

Breath Therapeutics has already received over 43 million euros in Series A<\/h2>\n\n\n\n

Back in 2017, the company raised approximately \u20ac43.5 million in one of Europe's largest Series A rounds to date. With the support of the investors, two studies were conducted on inhalation therapy solutions for the rare lung disease Bronchiolitis Obliterans Syndrome (BOS). There is currently no approved treatment for this often fatal disease. <\/p>\n\n\n\n

The Belgian, who is also based in Munich, Investor Gimv participated in March 2017 <\/a>along with other investors, together with Sofinnova Partners from France, as lead investor in the biotech startup. Pari Pharma served as licensor for the inhalation devices. Breath Therapeutics, as a Pari spin-off, was able to further develop the solution, tested the product in pivotal clinical trials, and simultaneously built a team of experts in Europe and the USA. Preparations are now continuing for the market launch.<\/p>\n\n\n\n

\u201cThe potential of Breath Therapeutics and the active ingredient was clear to us at an early stage, as lung diseases are unfortunately increasing rapidly \u2014 particularly due to environmental factors and changing lifestyles,\u201d<\/p><\/blockquote>\n\n\n\n

explained Karl N\u00e4gler<\/strong>, Partner and responsible for the Health & Care platform at Gimv Germany. He continues: <\/p>\n\n\n\n

\u201cAgainst this backdrop, Breath Therapeutics, with the support of Zambon, is in an excellent position to successfully market the product in the future and to open up new fields of application.\u201d<\/p><\/blockquote>\n\n\n\n

Jens Stegemann<\/strong>, CEO of Breath Therapeutics, adds: <\/p>\n\n\n\n

"With this active ingredient, Breath Therapeutics has developed a product that can significantly improve the lives of many people. Thanks to Zambon's infrastructure, expertise, and clear focus on research and development, we can accelerate these processes even further and make the treatment available to as many people as possible as quickly as possible."<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"

The Munich-based startup Breath Therapeutics has been acquired by the Italian Zambon Group for up to \u20ac500 million. Breath Therapeutics specializes in the development of inhalation solutions for severe lung diseases. The pharmaceutical company Zambon paid up to \u20ac500 million for the acquisition. According to Handelsblatt, this could be the third-largest...<\/p>","protected":false},"author":22,"featured_media":51523,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,1],"tags":[371,2361,243],"acf":[],"yoast_head":"\nExit f\u00fcr Biotech-Startup Breath Therapeutics - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Startup Breath Therapeutics wurde von der italienischen Zambon-Gruppe f\u00fcr eine Summe von bis zu 500 Millionen Euro aufgekauft.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/51346\/breath-therapeutics-taken-over\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exit f\u00fcr Biotech-Startup Breath Therapeutics - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Startup Breath Therapeutics wurde von der italienischen Zambon-Gruppe f\u00fcr eine Summe von bis zu 500 Millionen Euro aufgekauft.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/51346\/breath-therapeutics-taken-over\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-08-11T07:09:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-14T07:04:00+00:00\" \/>\n<meta name=\"author\" content=\"Helen Duran\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Helen Duran\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/\",\"url\":\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/\",\"name\":\"Exit f\u00fcr Biotech-Startup Breath Therapeutics - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg\",\"datePublished\":\"2019-08-11T07:09:35+00:00\",\"dateModified\":\"2019-10-14T07:04:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/9475cba0d0a1c75be607e20a2173385e\"},\"description\":\"Das M\u00fcnchner Startup Breath Therapeutics wurde von der italienischen Zambon-Gruppe f\u00fcr eine Summe von bis zu 500 Millionen Euro aufgekauft.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Breath Therapeutics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exit f\u00fcr Biotech-Startup Breath Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/9475cba0d0a1c75be607e20a2173385e\",\"name\":\"Helen Duran\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d704a78753d0b0da6407ce5550638f3d?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d704a78753d0b0da6407ce5550638f3d?s=96&d=blank&r=g\",\"caption\":\"Helen Duran\"},\"description\":\"Als Redakteurin ist die Wirtschaftsgeografin Helen Duran seit 2015 f\u00fcr Euch in der hiesigen Gr\u00fcnderszene unterwegs. Sie ist neugierig auf Eure spannenden Startup-Geschichten!\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/huettl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exit for biotech startup Breath Therapeutics - Munich Startup","description":"The Munich-based startup Breath Therapeutics was acquired by the Italian Zambon Group for a sum of up to 500 million euros.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/51346\/breath-therapeutics-taken-over\/","og_locale":"en_US","og_type":"article","og_title":"Exit f\u00fcr Biotech-Startup Breath Therapeutics - Munich Startup","og_description":"Das M\u00fcnchner Startup Breath Therapeutics wurde von der italienischen Zambon-Gruppe f\u00fcr eine Summe von bis zu 500 Millionen Euro aufgekauft.","og_url":"https:\/\/cms.munich-startup.net\/en\/51346\/breath-therapeutics-taken-over\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2019-08-11T07:09:35+00:00","article_modified_time":"2019-10-14T07:04:00+00:00","author":"Helen Duran","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Helen Duran","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/","url":"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/","name":"Exit for biotech startup Breath Therapeutics - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg","datePublished":"2019-08-11T07:09:35+00:00","dateModified":"2019-10-14T07:04:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/9475cba0d0a1c75be607e20a2173385e"},"description":"The Munich-based startup Breath Therapeutics was acquired by the Italian Zambon Group for a sum of up to 500 million euros.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg","width":1280,"height":853,"caption":"Breath Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/51346\/breath-therapeutics-ubernommen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Exit f\u00fcr Biotech-Startup Breath Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/9475cba0d0a1c75be607e20a2173385e","name":"Helen Duran","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d704a78753d0b0da6407ce5550638f3d?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d704a78753d0b0da6407ce5550638f3d?s=96&d=blank&r=g","caption":"Helen Duran"},"description":"As an editor, economic geographer Helen Duran has been working for you in the local startup scene since 2015. She's curious to hear your exciting startup stories!","url":"https:\/\/cms.munich-startup.net\/en\/author\/huettl\/"}]},"og_image":[{"width":1280,"height":853,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/addiction-antibiotic-capsules-159211-1.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1650374346:38","_edit_last":"22","_yoast_wpseo_focuskw":"Breath Therapeutics","_yoast_wpseo_metadesc":"Das M\u00fcnchner Startup Breath Therapeutics wurde von der italienischen Zambon-Gruppe f\u00fcr eine Summe von bis zu 500 Millionen Euro aufgekauft.","_yoast_wpseo_linkdex":"66","_thumbnail_id":"51523","wbounce_status":"default","_yoast_wpseo_primary_category":"5638","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"Exit","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/51346"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=51346"}],"version-history":[{"count":5,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/51346\/revisions"}],"predecessor-version":[{"id":53704,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/51346\/revisions\/53704"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/51523"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=51346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=51346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=51346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}